1. World Health Organization Global tuberculosis report http://www.who.int/tb/publications/global_report/en/ . Accessed: 3 Oct 2015.
2. U.S. Food and Drug Administration Press Announcements - FDA approves first drug to treat multi-drug resistant tuberculosis http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm333695.htm Accessed: 30 Nov 2015
3. Deoghare S. Bedaquiline: a new drug approved for treatment of multidrug-resistant tuberculosis. Indian J Pharmacol. 2013;45(5):536–7.
4. World Health Organization. The use of delamanid in the treatment of multidrug-resistant tuberculosis. 2014 http://www.who.int/tb/publications/delamanid-in-mdr-tb-treatment/en/ . Accessed: 30 Nov 2015
5. World Health Organization. Interim guidance on the use of bedaquiline to treat MDR-TB. 2013 http://www.who.int/tb/challenges/mdr/bedaquiline/en/ . Accessed: 30 Nov 2015.